AMIDX | RNWAX | AMIDX / RNWAX | |
Total Expense Ratio | 0.98 | 1.66 | 59% |
Annual Report Gross Expense Ratio | 0.98 | 1.66 | 59% |
Fund Existence | 12 years | 23 years | - |
Gain YTD | 1.274 | 12.671 | 10% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 250 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 139M | 68.6B | 0% |
Annual Yield % from dividends | 0.80 | 0.00 | - |
Returns for 1 year | -0.90 | 8.40 | -11% |
Returns for 3 years | 24.37 | 33.89 | 72% |
Returns for 5 years | 39.77 | 30.04 | 132% |
Returns for 10 years | 43.67 | 56.72 | 77% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
AVDV | 79.32 | 0.69 | +0.88% |
Avantis International Small Cap Val ETF | |||
MMD | 14.70 | 0.12 | +0.82% |
NYLI MacKay DefinedTerm Muni Opportunities Fund | |||
DFIP | 41.44 | 0.10 | +0.24% |
Dimensional Inflation-Protected Sec ETF | |||
BBP | 60.55 | 0.12 | +0.20% |
Virtus LifeSci Biotech Products ETF | |||
ISRA | 47.24 | -0.66 | -1.38% |
VanEck Israel ETF |